Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepac...

FDA Recall #D-0411-2025 — Class II — April 22, 2025

Recall #D-0411-2025 Date: April 22, 2025 Classification: Class II Status: Ongoing

Product Description

Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02

Reason for Recall

CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.

Recalling Firm

RemedyRePack Inc. — Indiana, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

23 bottles/30 count- 690 capsules

Distribution

Within U.S - PA, VA, FL.

Code Information

Lot#: B3698036-033125, B3688703-032625, Exp.: 07/31/2026.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated